Middle hepatic vein variation provides a safe path for anterior transection of hepatocellular carcinoma in caudate lobe
Bing-Yi Lin a , Qi-Jun Zhang b , Zhe Yang c , ∗, Shu-Sen Zheng a , c
a Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
b Department of Thyroid Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
c Division of Hepatobiliary Pancreatic Surgery, Shulan (Hangzhou) Hospital, Zhejiang Shuren University School of Medicine, Hangzhou 310000, China
Abstract：Hepatocellular carcinoma (HCC) is one of the main causes of cancer related death worldwide, and new cases are expected to continue to increase in future [1] . Surgical resection is still the best way to remove the tumor and improve patient’s prognosis. However, resection of caudate lobe often presents a technical challenge, even to accomplished hepatic surgeons. Caudate lobe is located anterior to the inferior vena cava (IVC) and posterior to the bifurcation of the portal vein (PV), generally consists of three regions: the paracaval portion, the left Spiegel lobe and the process portion [2] . The anatomy of the paracaval portion includes the liver parenchyma ventral to the hepatic IVC and the area between the Spiegel lobe and the right lobe adjacent to the middle hepatic vein (MHV) ventrally, which was classified by Couinaud as segment IX [3] . Here, we presented a case of HCC with successful downstaging therapy, as well as variation of MHV, which provides a safe path for anterior transection of segment IX.
引用本文:
. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 438-440.
Lin BY, Zhang QJ, Yang Z, Zheng SS. Middle hepatic vein variation provides a safe path for anterior transection of hepatocellular carcinoma in caudate lobe. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 438-440.
2024, Vol. 23 
